JPS6425718A - Oral solid drug for treating syndrome of epilepsy or spasm - Google Patents
Oral solid drug for treating syndrome of epilepsy or spasmInfo
- Publication number
- JPS6425718A JPS6425718A JP15246688A JP15246688A JPS6425718A JP S6425718 A JPS6425718 A JP S6425718A JP 15246688 A JP15246688 A JP 15246688A JP 15246688 A JP15246688 A JP 15246688A JP S6425718 A JPS6425718 A JP S6425718A
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparations
- pharmaceutical
- treating
- syndrome
- spasmodic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: To prepare a orally administered solid pharmaceutical for treating an epileptic seizure or spasmodic syndrome that enables easy production of solid pharmaceutical preparations having reduced hygroscopicity and improved stability while retaining an efficacy equivalent to or more than that of conventional pharmaceutical preparations by using crystalline single compound consisting of valpronic acid and sodium valproate at a specific mol ratio as the main active component. CONSTITUTION: This orally administered solid pharmaceutical effective for treating an epileptic seizure or spasmodic syndrome comprises a crystalline single compound consisting of valpronic acid and sodium valproate at a mol ratio of (1:1), and one or more excipients or diluents which are permitted for pharmaceutical preparations, thereby enabling production of pharmaceutical preparations in the solid form without special precautions and use of absorbents because its non-hygroscopicity and very high stability while exhibiting its efficacy of the same degree as that of the liquid valpronic acid and its sodium salt, which is hygroscopic and unstable. A specific amount of this pharmaceutical is mixed with starch and/or other binders to make a flowable powdery mixture, and the powdery mixture is granulated and then pelletized through a pelletizer, to provide the excellent pellets.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15246688A JPS6425718A (en) | 1988-06-22 | 1988-06-22 | Oral solid drug for treating syndrome of epilepsy or spasm |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15246688A JPS6425718A (en) | 1988-06-22 | 1988-06-22 | Oral solid drug for treating syndrome of epilepsy or spasm |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6425718A true JPS6425718A (en) | 1989-01-27 |
JPH0160452B2 JPH0160452B2 (en) | 1989-12-22 |
Family
ID=15541128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15246688A Granted JPS6425718A (en) | 1988-06-22 | 1988-06-22 | Oral solid drug for treating syndrome of epilepsy or spasm |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6425718A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1479291A1 (en) | 2003-05-19 | 2004-11-24 | Shotaro Mochizuki | Discharged waste processing materials for animals |
-
1988
- 1988-06-22 JP JP15246688A patent/JPS6425718A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1479291A1 (en) | 2003-05-19 | 2004-11-24 | Shotaro Mochizuki | Discharged waste processing materials for animals |
Also Published As
Publication number | Publication date |
---|---|
JPH0160452B2 (en) | 1989-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU587863B2 (en) | Vitamin-containing granules and production thereof | |
GB1226394A (en) | ||
US2950309A (en) | Amphetamine tannate | |
KR20040012569A (en) | Pharmaceutical compositions with antibiotic activity | |
JPS6425718A (en) | Oral solid drug for treating syndrome of epilepsy or spasm | |
JPS5610110A (en) | Acetyl salicylate salt preparation for injection | |
JPS552601A (en) | Anti-tumor agent for non-injection use | |
JPS5599164A (en) | Feed for germfree animal, and its preparation | |
JPS5347515A (en) | Gamma-globulin pharmaceutical preparation for intravenous injection | |
JPS5334716A (en) | Preparation of amide amine amphoteric surface active agent | |
GB1359560A (en) | Preparation of pyrrylsalicylic acid | |
IE44704L (en) | ß-LACTAM ANTIBIOTIC | |
GB1187946A (en) | Dimethylbiguanide Derivative | |
EP0127274A3 (en) | Esters of metronidazole and compositions containing them | |
JPS5668672A (en) | Novel 2-acetoxybenzamide derviative, its preparation, and pharmaceutical containing said derviative as effective component | |
JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
GB1470747A (en) | Pyridazine derivative | |
ES8502436A1 (en) | A compound with analgesic and anti-inflammatory activity, a process for producing same and related pharmaceutical compositions | |
DE3472554D1 (en) | Cysteine derivatives, a process for their preparation, and pharmaceutical compostions which contain them | |
GB1125793A (en) | Complexes of bismuth and chlorohydroxyquinoline and compositions containing them | |
JPS51115402A (en) | Process for preparation of alpha-amino acid | |
ES8505644A1 (en) | S-Carboxymethylcysteine derivatives having a therapeutic activity, process for their preparation and pharmaceutical compositions which contain them | |
ES8107049A1 (en) | Acid-type ion exchange resins, their preparation, their use as medicines and compositions containing them. | |
JPS55108257A (en) | Method for preventing laying of abnormal egg of quail, and powdery feed for quail | |
JPS57114510A (en) | Hemostatic and platelet-increasing agent comprising d-beta- n-oxalo-alpha,beta-diaminopropionic acid |